Home » Topics » Disease categories and therapies » Immune

Immune
RSS

New emulsion formulation of tacrolimus provides local immunosuppression

July 30, 1997

SangStat Medical reports encouraging phase III results with Thymoglobulin

July 29, 1997

DynaGen expands ImmuDyn development

July 24, 1997

Mycophenolic acid derivatives with immunosuppressive activity claimed

July 17, 1997

Intranasal flu vaccine effective and safe in children

July 16, 1997

Vical and Pasteur Merieux Connaught initiate phase I malaria trial

July 14, 1997

Virus Research Institute's rotavirus vaccine enters phase II

July 11, 1997

Lepetit discovers IL-1RI inhibitors from microbial samples

July 10, 1997

FDA grants manufacturing approval for bulk ciclosporin

July 8, 1997

Preliminary results reported for Cortecs' Flustat

July 7, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...